Unknown Company Form SCHEDULE 13D/A — Oct 2, 2026
An 11-member shareholder group in Genenta Science S.p.A. filed Amendment No. 1 to its Schedule 13D, reporting a decrease in its stake to 5,543,910 shares, or 11.5% of the 48,216,858 shares outstanding, representing about 18.94% of voting power. The dilution stems from the issuer's allotment of 24,625,838 new shares on May 29, 2026 in connection with an amendment to the A.T.C transaction.
Key figures
- Shares Outstanding
- 48216858
- Total Votes
- 109436695
- New Shares Issued
- 24625838
- Group Shares Owned
- 5543910
- Group Percent Owned
- 11.5%
- Posillipo Total Cost
- $143,000.00
- Posillipo Ads Purchased
- 110000
- Posillipo Purchase Price
- $1.30/ADS
- Group Voting Power Percent
- 18.94%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.